Literature DB >> 6992976

Cell-mediated immunity in patients with mycosis fungoides in clinical remission: effect of thymic humoral factor on the immunocompetence of the lymphocytes.

M David, B Shohat, N Trainin, E Feuerman.   

Abstract

In 10 patients with mycosis fungoides (MF) who were in clinical remission following local treatment with nitrogen mustard, cell-mediated immunity was investigated by means of tests for lymphocytes, forming rosettes in the peripheral blood, and the graft-vs-host reaction as well as intradermal skin tests. The effect of thymic humoral factor (THF) on T lymphocytes with impaired immunecompetence was also investigated. The results provided evidence of various kinds of damage to the immunologic system in most of the patients. Of the 10 patients, 4 had low percentages of T cells. Eight of the 10 had a graft-vs.-host reaction which was weak or negative, and in 4 of these, the administration of THF to the lymphocytes induced an improvement in immunoreactivity. These results together with other recently reported data indicate that the determination of cell-mediated immunity in patients with MF may be of prognostic importance. Those patients whose T lymphocytes respond to treatment with THF are probably the best candidates for immunotherapy.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6992976     DOI: 10.1002/1097-0142(19800701)46:1<41::aid-cncr2820460110>3.0.co;2-0

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  2 in total

1.  THF-gamma 2, a thymic hormone, increases immunocompetence and survival in 5-fluorouracil-treated mice bearing MOPC-315 plasmacytoma.

Authors:  R Ophir; M Pecht; D Halperin; G Rashid; Y Burstein; S Ben-Efraim; N Trainin
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Crazy-Paving Pattern Due to Herpetic Pneumonia in a Patient with Mycosis Fungoides: A Case Report.

Authors:  Ramin Sami; Sara Aeini; Raheleh Sadegh
Journal:  Tanaffos       Date:  2017-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.